Imatinib mesylate

Overview

Imatinib (INN), marketed by Novartis as Gleevec (Canada, South Africa and the USA) or Glivec (Australia, Europe and Latin America), and sometimes referred to by its investigational name STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML).

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | c-Kit

Product Information

• Catalog No.: B2692-333257
• CAS No.: 220127-57-1
• Molecular Formula: C29H31N7O.CH4SO3
• Molecular Weight: 589.71
• Purity: >98%
• Storage: 2-8°C

Source

Original product source